CA2079796A1 - Derives de nucleosides - Google Patents

Derives de nucleosides

Info

Publication number
CA2079796A1
CA2079796A1 CA002079796A CA2079796A CA2079796A1 CA 2079796 A1 CA2079796 A1 CA 2079796A1 CA 002079796 A CA002079796 A CA 002079796A CA 2079796 A CA2079796 A CA 2079796A CA 2079796 A1 CA2079796 A1 CA 2079796A1
Authority
CA
Canada
Prior art keywords
group
groups
formula
compounds
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002079796A
Other languages
English (en)
Inventor
Jo Klaveness
Kjell Undheim
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GE Healthcare AS
Original Assignee
Nycomed AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27265029&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA2079796(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB909007650A external-priority patent/GB9007650D0/en
Priority claimed from GB909007651A external-priority patent/GB9007651D0/en
Priority claimed from GB909007566A external-priority patent/GB9007566D0/en
Application filed by Nycomed AS filed Critical Nycomed AS
Publication of CA2079796A1 publication Critical patent/CA2079796A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
CA002079796A 1990-04-04 1991-04-04 Derives de nucleosides Abandoned CA2079796A1 (fr)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
GB9007566.4 1990-04-04
GB909007650A GB9007650D0 (en) 1990-04-04 1990-04-04 Nucleoside derivatives
GB9007650.6 1990-04-04
GB9007651.4 1990-04-04
GB909007651A GB9007651D0 (en) 1990-04-04 1990-04-04 Nucleoside derivatives
GB909007566A GB9007566D0 (en) 1990-04-04 1990-04-04 Nucleoside derivatives
PCT/EP1991/000639 WO1991015498A2 (fr) 1990-04-04 1991-04-04 Derives nucleosidiques

Publications (1)

Publication Number Publication Date
CA2079796A1 true CA2079796A1 (fr) 1991-10-05

Family

ID=27265029

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002079796A Abandoned CA2079796A1 (fr) 1990-04-04 1991-04-04 Derives de nucleosides

Country Status (6)

Country Link
EP (1) EP0523110A1 (fr)
JP (1) JPH05505815A (fr)
AU (1) AU7558491A (fr)
CA (1) CA2079796A1 (fr)
OA (1) OA09677A (fr)
WO (1) WO1991015498A2 (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991006554A1 (fr) * 1989-11-06 1991-05-16 Nycomed As Derives de nucleosides
UA41261C2 (uk) * 1992-06-22 2001-09-17 Елі Ліллі Енд Компані Спосіб одержання збагачених бета-аномером нуклеозидів
YU43193A (sh) * 1992-06-22 1997-01-08 Eli Lilly And Company 2'-deoksi-2',2'-difluoro(4-supstituisani)pirimidinski nukleozidi antivirusnog i antikancerogenog dejstva i međuproizvodi
JPH0692987A (ja) * 1992-09-17 1994-04-05 Tanabe Seiyaku Co Ltd ウリジン誘導体およびその製法
JPH11217396A (ja) * 1998-01-30 1999-08-10 Ajinomoto Co Inc ヌクレオシド誘導体の製造方法
US6326507B1 (en) 1998-06-19 2001-12-04 Trustees Of Dartmouth College Therapeutic compounds and methods of use
US7435755B2 (en) 2000-11-28 2008-10-14 The Trustees Of Dartmouth College CDDO-compounds and combination therapies thereof
CA2472581C (fr) 2002-01-15 2012-06-26 Trustees Of Dartmouth College Derives de bis-enone tricyclique et methodes d'utilisation
WO2004041203A2 (fr) * 2002-11-04 2004-05-21 Xenoport, Inc. Promedicaments de gemcitabine, leurs compositions pharmaceutiques et leurs utilisations
CN1693309A (zh) * 2005-04-18 2005-11-09 成都正开生物科技发展有限公司 N4－（取代的氧羰基）－2′，2′－二氟－2′－脱氧胞苷衍生物及其应用
WO2008064132A2 (fr) 2006-11-17 2008-05-29 Trustees Of Dartmouth College Triterpénoïdes synthétiques et bis-énones tricycliques pour une utilisation dans la stimulation de croissance osseuse et cartilagineuse
CA2670099A1 (fr) 2006-11-17 2008-05-29 Trustees Of Dartmouth College Synthese et activites biologiques de nouveaux composes tricycliques-bis-enones (tbe)
US8921340B2 (en) 2006-11-17 2014-12-30 Trustees Of Dartmouth College Methods for using synthetic triterpenoids in the treatment of bone or cartilage diseases or conditions
TW200942231A (en) 2008-01-11 2009-10-16 Reata Pharmaceuticals Inc Synthetic triterpenoids and methods of use in the treatment of disease
TW201004627A (en) 2008-04-18 2010-02-01 Reata Pharmaceuticals Inc Antioxidant inflammation modulators: novel derivatives of oleanolic acid
WO2009129545A1 (fr) 2008-04-18 2009-10-22 Reata Pharmaceuticals, Inc. Modulateurs d'inflammation antioxydants: dérivés d'acide oléanolique présentant une saturation dans l'anneau c
CN104250280A (zh) 2008-04-18 2014-12-31 里亚塔医药公司 抗氧化剂炎症调节剂:c-17同系化齐墩果酸衍生物
JP5564490B2 (ja) 2008-04-18 2014-07-30 リアタ ファーマシューティカルズ インコーポレイテッド 抗炎症性ファルマコアを含む化合物および使用法
NZ588710A (en) 2008-04-18 2012-12-21 Reata Pharmaceuticals Inc Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at C-17
JP6042527B2 (ja) 2012-04-04 2016-12-14 ハロザイム インコーポレイテッド 抗ヒアルロナン剤と腫瘍標的タキサンの組み合わせ治療
US8921419B2 (en) 2012-05-08 2014-12-30 Trustees Of Dartmouth College Triterpenoids and compositions containing the same
WO2016078160A1 (fr) * 2014-11-17 2016-05-26 常州方圆制药有限公司 Dérivé de cytidine et application de celui-ci
WO2016078397A1 (fr) * 2014-11-17 2016-05-26 常州方圆制药有限公司 Nouveau type de dérivé de cytidine et application de celui-ci
WO2019222435A1 (fr) 2018-05-16 2019-11-21 Halozyme, Inc. Procédés de sélection de sujets pour une polythérapie anticancéreuse avec un ph20 soluble conjugué à un polymère
GR1009958B (el) * 2019-04-24 2021-03-18 ΕΝΟΡΑΣΙΣ ΑΝΩΝΥΜΗ ΕΜΠΟΡΙΚΗ ΕΤΑΙΡΕΙΑ ΦΑΡΜΑΚΕΥΤΙΚΩΝ ΚΑΙ ΙΑΤΡΙΚΩΝ ΥΛΙΚΩΝ ΚΑΙ ΜΗΧΑΝΗΜΑΤΩΝ με δ.τ. "ΕΝΟΡΑΣΙΣ Α.Ε." Παραγωγα γεμσιταβινης και μεθοδοι δημιουργιας παραγωγων γεμσιταβινης

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3651045A (en) * 1968-10-21 1972-03-21 Parke Davis & Co 9-(beta-d-arabinofuranosyl)adenine esters and methods for their production
FI70903C (fi) * 1980-06-23 1986-10-27 Univ Minnesota Foerfarande foer framstaellning av terapeutiskt aktiva adeninnukleosidderivat
DE3100478A1 (de) * 1981-01-09 1982-08-12 Dr. Thilo & Co GmbH, 8021 Sauerlach 5'ester von pyrimidinnucleosiden mit antiviraler wirksamkeit, verfahren zur herstellung und daraus hergestellte arzneimittel
US4495180A (en) * 1982-06-21 1985-01-22 Merck & Co., Inc. Prodrugs of Ara-A an antiviral agent
EP0104857A1 (fr) * 1982-09-28 1984-04-04 Beecham Group Plc Dérivés de la déoxyuridine, leurs méthodes de préparation et leur emploi en médecine
DE3481191D1 (de) * 1983-07-20 1990-03-08 Teijin Ltd Antineoplastisches mittel.
ATE190064T1 (de) * 1985-09-17 2000-03-15 Wellcome Found Kombination therapeutische nukleoside mit weiteren therapeutisch wirksamen komponenten.
US4751221A (en) * 1985-10-18 1988-06-14 Sloan-Kettering Institute For Cancer Research 2-fluoro-arabinofuranosyl purine nucleosides
US4780452A (en) * 1986-09-08 1988-10-25 Burroughs Wellcome Co. F-substituted-3-β-D-ribofuranosyl-3H-imidazo[4,5-b]pyridines and pharmaceutical compositions thereof
AU613026B2 (en) * 1987-03-24 1991-07-25 Nycomed As 2',3' dideoxyribofuranoxide derivatives
IL89258A0 (en) * 1988-02-16 1989-09-10 Lilly Co Eli 2',3'-dideoxy-2',2'-difluoro-nucleosides
JPH02152976A (ja) * 1988-05-06 1990-06-12 Bristol Myers Co ２´，３´―ジデヒドロ―２´，３´―ジデオキシヌクレオシドのプロドラッグ
US4900828A (en) * 1988-05-12 1990-02-13 Hoffmann-Laroche Inc. Intermediate compounds and an improved procedure for the synthesis of 2',3'-dideoxycytidine
EP0346108A3 (fr) * 1988-06-09 1991-04-24 The Wellcome Foundation Limited Nucléosides anti-infectieux
EP0355031A3 (fr) * 1988-08-17 1990-12-27 MATTHES, Eckart, Dr. Nucléosides pyrimidiniques substitués, leur procédé de préparation et médicaments les contenant
GB8823319D0 (en) * 1988-10-05 1988-11-09 Nycomed As Chemical compounds
GB8823320D0 (en) * 1988-10-05 1988-11-09 Nycomed As Chemical compounds
GB8920534D0 (en) * 1989-09-11 1989-10-25 Wellcome Found Antiviral compounds

Also Published As

Publication number Publication date
WO1991015498A2 (fr) 1991-10-17
JPH05505815A (ja) 1993-08-26
WO1991015498A3 (fr) 1992-06-11
OA09677A (en) 1993-05-15
EP0523110A1 (fr) 1993-01-20
AU7558491A (en) 1991-10-30

Similar Documents

Publication Publication Date Title
CA2079796A1 (fr) Derives de nucleosides
US6525191B1 (en) Conformationally constrained L-nucleosides
WO2004084453A2 (fr) Procedes de fabrication de 2'-desoxy-$g(b)-l-nucleosides
US20050187384A1 (en) Process for the preparation of 2'-halo-beta-L-arabinofuranosyl nucleosides
RU2361875C2 (ru) СИНТЕЗ β-L-2'-ДЕЗОКСИНУКЛЕОЗИДОВ
AU636678B2 (en) Nucleoside derivatives
AU2002303187A1 (en) Process for the preparation of 2'-HALO-Beta-L-arabinofuranosyl nucleosides
Yoshimura et al. Synthesis and biological evaluation of 1′-C-cyano-pyrimidine nucleosides
HONJO et al. Synthesis and biological evaluation of phosphonopyrimidine and phosphonopurine ribonucleosides
WO1990004602A1 (fr) Derives de nucleoside
AU7695991A (en) Carbo-nucleoside derivatives
Kotra et al. Synthesis of 2, 3-dideoxy-2, 2-difluoro-L-glycero-pentofuranosyl nucleosides
WO2004096149A2 (fr) Synthese de nucleosides pouvant etre mise a l'echelle industrielle
Bolon et al. Homologues of anti-HIV active isodideoxynucleosides
EP0437527A1 (fr) Derives de nucleoside
JPH08512317A (ja) Ｄｎａポリメラーゼ基質としてのジデオキシフルクトヌクレオチドおよびデオキシフルクトヌクレオチド

Legal Events

Date Code Title Description
FZDE Dead